Minimal deviation melanoma

Cancer Treatment Reviews

Volumn 28, Issue 5, 2002, Pages 219-221

  Podnos, Y D ^a   Jimenez, J C ^a   Zainabadi, K ^a   Jakowatz, J G ^a   Barr, R J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR;

ADOLESCENT; ADULT; AGE; AGED; CANCER INVASION; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MEDICAL LITERATURE; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; METASTASIS; PATHOLOGY; PROGNOSIS; PUBLISHING; REVIEW; SENTINEL LYMPH NODE BIOPSY; TUMOR LOCALIZATION;

EID: 0036816209     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(02)00035-X     Document Type: Review

References (6)

1. Phillips ME, Margolis RJ, Merot Y, et al. The spectrum of minimal deviation melanomas: a clinicopathologic study of 21 cases. Hum Path 1986; 17: 796-806.
2. Reed RJ. Minimal deviation melanoma. Hum Path 1990; 21: 1206-1211.
3. Reed RJ, Ichinose H, Clarke WH, et al. Common and uncommon melanocytic nevi and borderline melanomas. Semin Oncol 1975; 2: 119-147.
4. Reed RJ. The histologic variance of malignant melanoma: the interrelationship of histologic subtype, neoplastic progression, and biologic behavior. Pathology 1985; 17: 301-312.
5. Barr LH, Goldman LI, Solomon JA, et al. Minimal deviation melanomas. Surg Gyn Obstet 1984; 159: 546-548.
6. Becker DW, Miller CJ, Keller HB. Metastatic minimal deviation melanoma. Ann Plast Surg 1979; 4: 230-237.